Gossamer Bio (GOSS)
(Delayed Data from NSDQ)
$0.82 USD
0.00 (-0.10%)
Updated Apr 17, 2024 04:00 PM ET
After-Market: $0.83 +0.01 (1.22%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth C Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/14/24 |
---|---|
Current Quarter | -0.19 |
EPS Last Quarter | -0.21 |
Last EPS Surprise | -5.00% |
ABR | 1.67 |
Earnings ESP
|
-5.26% |
---|---|
Current Year | -0.75 |
Next Year | -0.82 |
EPS (TTM) | -1.39 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.19 | -0.19 | -0.75 | -0.82 |
# of Estimates | 4 | 4 | 5 | 4 |
Most Recent Consensus | -0.20 | -0.20 | -0.81 | -0.82 |
High Estimate | -0.15 | -0.16 | -0.61 | -0.57 |
Low Estimate | -0.23 | -0.23 | -0.94 | -1.00 |
Year ago EPS | -0.52 | -0.45 | -1.18 | -0.75 |
Year over Year Growth Est. | 63.46% | 57.78% | 36.44% | -8.93% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 3 | 3 | 4 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 60 Days | 0 | 0 | 1 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.19 | -0.19 | -0.75 | -0.82 |
7 Days Ago | -0.19 | -0.19 | -0.75 | -0.82 |
30 Days Ago | -0.18 | -0.19 | -0.72 | -0.79 |
60 Days Ago | -0.21 | -0.21 | -1.07 | -0.73 |
90 Days Ago | -0.21 | -0.21 | -1.05 | -0.77 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.20 | -0.20 | -0.81 | -0.82 |
Zacks Consensus Estimate | -0.19 | -0.19 | -0.75 | -0.82 |
Earnings ESP | -5.26% | -3.90% | -8.29% | -0.61% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.21 | -0.21 | -0.45 | -0.52 | NA |
Estimate | -0.20 | -0.20 | -0.49 | -0.55 | NA |
Difference | -0.01 | -0.01 | 0.04 | 0.03 | 0.01 |
Surprise | -5.00% | -5.00% | 8.16% | 5.45% | 0.90% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more